These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7699254)

  • 1. Evaluation of different serum RNA extraction protocols using quantitative HCV-PCR.
    Goergen B; Jakobs S; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1994 Dec; 21(6):1157. PubMed ID: 7699254
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of hepatitis C virus (HCV) by reverse transcription-polymerase chain reaction (RT-PCR) (a note).
    Falus A; Hajnal A
    Acta Microbiol Immunol Hung; 1995; 42(2):235-6. PubMed ID: 7551719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of inhibitors of enzymatic amplification in polymerase chain reaction and evaluation of efficacy of RNA extraction for the detection of hepatitis C virus using the internal control.
    Miyachi H; Masukawa A; Ohshima T; Fusegawa H; Hirose T; Impraim C; Ando Y
    Clin Chem Lab Med; 1998 Aug; 36(8):571-5. PubMed ID: 9806462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.
    Schröter M; Zöllner B; Schäfer P; Laufs R; Feucht HH
    J Clin Microbiol; 2001 Feb; 39(2):765-8. PubMed ID: 11158147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR.
    Beuselinck K; van Ranst M; van Eldere J
    J Clin Microbiol; 2005 Nov; 43(11):5541-6. PubMed ID: 16272483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intercalation monitoring PCR(IM-PCR), its principle and application: quantitative monitoring of HCV RNA in the course of IFN therapy].
    Ishiguro T; Saitoh J
    Rinsho Byori; 1997 Mar; 45(3):213-7. PubMed ID: 9086823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.
    Zeuzem S; Rüster B; Roth WK
    Z Gastroenterol; 1994 Jun; 32(6):342-7. PubMed ID: 7526563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.
    Enomoto M; Nishiguchi S; Shiomi S; Tanaka M; Yokogawa T; Fukuda K; Ueda T; Tamori A; Habu D; Takeda T; Yano Y; Otani S
    Am J Gastroenterol; 2002 Feb; 97(2):420-6. PubMed ID: 11866282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct PCR from serum: application to viral genome detection.
    Abe K
    Methods Mol Biol; 2003; 226():161-6. PubMed ID: 12958496
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative method of intracellular hepatitis C virus RNA using LightCycler PCR.
    Nozaki A; Kato N
    Acta Med Okayama; 2002 Apr; 56(2):107-10. PubMed ID: 12002616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.
    Comanor L; Anderson F; Ghany M; Perrillo R; Heathcote EJ; Sherlock C; Zitron I; Hendricks D; Gordon SC
    Am J Gastroenterol; 2001 Oct; 96(10):2968-72. PubMed ID: 11693334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens.
    Padley DJ; Lucas SB; Saldanha J
    Transplantation; 2003 Jul; 76(2):432-4. PubMed ID: 12883207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of hepatitis C virus and human immunodeficiency virus RNA in serum using amplicor PCR tests.
    Woźny W; Piasek A; Elbaum D
    Viral Immunol; 1997; 10(2):73-82. PubMed ID: 9210281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum versus intrahepatic HCV RNA and liver histology in anti-HCV-positive serum PCR-negative individuals.
    Barrett S; Ryan E; Crowe J
    Hepatology; 2003 Jan; 37(1):223-4. PubMed ID: 12500210
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method.
    Roth WK; Lee JH; Rüster B; Zeuzem S
    Z Gastroenterol; 1998 Jan; 36(1):5-11. PubMed ID: 9531684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitation of HCV-RNA by competitive-PCR].
    Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):281-6. PubMed ID: 7563725
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment.
    Gerken G; Knolle P; Jakobs S; Meyer zum Büschenfelde KH
    Arch Virol; 1997; 142(3):459-64. PubMed ID: 9349292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.